Payal Kohli, MD, FACC

DocwireNews

The use of statins, which have been shown to help prevent ischemic strokes, may also prevent deadly hemorrhagic stroke, particularly over a longer treatment duration, according to a recent study <a href="https://n.neurology.org/content/early/2022/12/07/WNL.0000000000201664" target="_blank" rel="noopener">published</a> in Neurology.
DocWire News Medical Lead Dr. Payal Kohli, spoke about this study, and why its findings back the benefits of using statins to prevent many cardiovascular diseases.
DocWire News: How many people in the U.S. suffer from stroke each year, and what are the risk factors?
Dr. Payal Kohli: There&#8217;s two different types of strokes that we worry about the most, and stroke is a form of cardiovascular disease because it&#8217;s usually a problem with the blood vessels. And so the first is the ischemic stroke, which means you have a blood clot in the blood vessels that&#8217;s preventing the blood from flowing. And that obviously, depending on the size of area involved of the tissue affected in the brain, can have significant morbidity and mortality. The other type of stroke is a hemorrhagic stroke. That&#8217;s a bleeding type of stroke. That&#8217;s where the blood vessel pops open and causes bleeding, and that can cause damage and lack of blood flow to tissues as well. Now, the ischemic strokes can convert into hemorrhagic strokes, and people who have one sometimes also have a risk factor for the other because a lot of the risk factors are the same. It&#8217;s things that really damage the walls of the blood vessels.
The most common being, of course, hypertension or high blood pressure because that can cause the blood vessels not only to get sticky, but also possibly rupture open and cause problems with inflammation in the walls of the blood vessels. High cholesterol is another risk factor because that&#8217;s what leads to those cholesterol deposits and those sticky blood vessels. Diabetes. Diabetes means excess sugar swimming around in our bloodstream, and that causes the walls of the blood vessels to have more inflammation. It can also change hormones and chemicals that are released that cause more inflammation. Obesity is another risk factor for stroke, particularly in women, but really in both genders. Smoking is a big one. It&#8217;s a huge risk factor as well because again, it affects the inflammation, the walls of the arteries.
And then other lifestyle factors as well, such as, in younger women especially, birth control use. So, in a young woman who uses birth control and smokes, that&#8217;s kind of the biggest risk that you can really have for having some of these types of strokes. So, a lot of modifiable risk factors that are within our control and things that we can really change with medication use.
A recent study published in Neurology found that statins can reduce the risk of hemorrhagic stroke &#8211; can you talk to us about this study?
Very interesting because there&#8217;s a lot of fear about statins out there in the scientific community and even potentially among some providers because there have been some observational studies, some research, that suggests that in people who may have had an ischemic stroke, giving them a statin could actually increase the risk downstream of a hemorrhagic stroke. We worry about lowering the LDL too much and how it affects bleeding, particularly in the brain, and all of those types of factors. As we know, statins are one of the most ubiquitous and widely used medications in, of course, in people who have stroke. It&#8217;s a Class 1 guideline indication, but also for prevention of strokes. So, this is a really important question, and this study essentially looked at a large number of people from Denmark, so 88,000 people, so really nice, long, large study. None of those people had a prior history of stroke.
So, this is that primary prevention. We&#8217;re sort of following people over time to see if they developed stroke. And then it followed people to see, based on whether or not they used statins and for how long they used statins, whether or not they ended up developing a hemorrhagic stroke, a bleeding type of stroke that occurred. And it found that if they used statins for any period of time, there was about a 16 to 17% lower chance of having a hemorrhagic stroke. We&#8217;ve known the data about ischemic stroke for a long time, but this was a really pleasant surprise. And in fact, if they use statins for longer, so if they used it for five or more years, they actually had a 33 to 38% reduction in those hemorrhagic strokes. And so to me, this is a very, very important sort of definitive answer to knowing that statins really do prevent strokes and many of us can start to feel more reassured about it.
Now, one thing to keep in mind about the study and some of its limitations are that it was a single country study, so it&#8217;s a specific population. So, how does that generalize to other races, other ethnicities, and other populations? That&#8217;s a little bit of a question mark. Also, the other thing to keep in mind is because of the design of the study, where they used it, I looked at prescription data and health records. Sometimes they couldn&#8217;t completely adjust for other factors, lifestyle factors and other risk factors for stroke, that could have been confounding the situation. In other words, using a statin may have been a marker of a more healthier lifestyle and not necessarily the statin itself that reduces the risk of stroke, but is just kind of associated with the lower risk of stroke. So, more information, of course, is needed. More studies are needed to know this for sure. But as somebody who writes statin prescriptions multiple times a day, I feel very reassured by this data, and this is something I can certainly talk to my patients about as well.
What are the key takeaways of this study?
The key takeaways I would say are that statins save lives. We have known for many decades now that the lower you get your LDL cholesterol, the less your chance of having a major adverse cardiovascular event, including cardiovascular death, myocardial infarction, and stroke. The fear about the adverse effects of statins, whether that comes to slightly higher hemoglobin A1C or some of the concerns that have been raised about hemorrhagic stroke, some of the other concerns about neurocognitive effects of statins, we have now seen a wealth of data coming out of many different types of studies, observational, randomized in others, that really reassure us about the safety of this medication on a population level and on an individual level. So, I feel like we should be now more empowered than ever to give our patients this life-saving therapy and to really tell them that not only are we reducing their risk of heart attack, a risk of a clotting stroke, but we&#8217;re actually now&#8230; Have data that suggests we&#8217;re also reducing their risk of a bleeding stroke.

Cecilia Brown

FDA Approves Ensartinib for ALK-Positive Locally Advanced or Metastatic NSCLC

Non-Small Cell Lung Cancer

Karine Tawagi, MD

An Overview of Notable Data from the 2024 San Antonio Breast Cancer Symposium

SABCS 2024

The Evolving Standard of Care in Metastatic Triple-Negative Breast Cancer

SABCS 2024: Expert on Site

Latest News

Dr. Kohli On Statins Reducing Risk of Hemorrhagic Stroke

Payal Kohli, MD, FACC, is a noninvasive cardiologist and managing partner of Cherry Creek Heart in Denver, Colorado. Clinically, Dr. Kohli’s interests are in preventive cardiology, echocardiography and heart disease in women. She has published in leading journals, including JAMA, Lancet, Circulation, and JACC. She was the Associate Editor of JACC Imaging, the inaugural Media Editor for JACC, and is the current section editor of Women and Ischemic Heart Disease for Current Atherosclerosis.  She is also on the editorial board for the Prevention Council of ACC.org and is the Chief Editor in Cardiology Consult on Medscape.

Payal Kohli

The use of statins, which have been shown to help prevent ischemic strokes, may also prevent deadly hemorrhagic stroke, particularly over a longer treatment duration, ...

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Hurricanes & Health Care

Career Center

Expert Interviews

Subscribe